Trial NCT00132730

View at ClinicalTrials.gov 
Org. Study IDs: 0873-005
Secondary IDs: 2005_015

Last trial update was posted on 2018-10-12

MeSH Interventions

MK 0873

MeSH Conditions

Lung Diseases Pulmonary Disease, Chronic Obstructive

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

The extension studies were terminated based on data from the completed base study suggesting that MK-0873, at doses up to 2.5 mg per day, demonstrated no benefits versus placebo in lung function or symptoms in participants with COPD.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID